BIOR
Biora Therapeutics Inc
NASDAQ: BIOR · HEALTHCARE · BIOTECHNOLOGY
$0.22
+0.00% today
Updated 2026-04-30
Market cap
$994990.00
P/E ratio
0.61
P/S ratio
0.74x
EPS (TTM)
$0.36
Dividend yield
—
52W range
$0 – $0
Volume
—
Biora Therapeutics Inc (BIOR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+43.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-3.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-09-30 | $-3.85 | $-5.04 | -30.9% | $32000.00 | — |
| 2024-06-30 | $-0.45 | $0.18 | +140.0% | $318000.00 | +15800.0% |
| 2024-03-31 | $-0.45 | $-0.14 | +68.9% | $542000.00 | +27000.0% |
| 2023-12-31 | $-0.59 | $-0.62 | -5.1% | — | — |
| 2023-09-30 | $-0.92 | $-4.89 | -431.5% | — | — |
| 2023-06-30 | $-1.60 | $-1.47 | +8.1% | $2000.00 | -98.1% |
| 2023-03-31 | $-1.75 | $-1.59 | +9.1% | $2000.00 | -98.1% |
| 2022-12-31 | $-1.44 | $-1.64 | -13.9% | $14000.00 | -96.8% |
| 2022-09-30 | $-1.87 | $-0.75 | +59.9% | $80000.00 | — |
| 2022-06-30 | $-3.00 | $-0.75 | +75.0% | $104000.00 | — |
| 2022-03-31 | $-3.12 | $-2.00 | +35.9% | $107000.00 | — |
| 2021-12-31 | $-4.00 | $-14.00 | -250.0% | $435000.00 | — |
Frequently asked questions
Has Biora Therapeutics Inc beaten earnings estimates?
Biora Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +43.2% over the last 4 quarters.